These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23357595)

  • 1. Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma.
    Ahn D; Sohn JH; Kim JH; Shin CM; Jeon JH; Park JY
    Am J Otolaryngol; 2013; 34(4):312-9. PubMed ID: 23357595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of papillary thyroid carcinoma in relation to preoperative subclinical hypothyroidism.
    Kang SY; Ahn HR; Youn HJ; Jung SH
    Ann R Coll Surg Engl; 2021 May; 103(5):367-373. PubMed ID: 33682437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
    Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
    Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer.
    Kim WW; Park HY; Jung JH
    Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
    Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
    World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
    Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
    Xia Q; Dong S; Bian PD; Wang J; Li CJ
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma.
    Zhang L; Liu H; Xie Y; Xia Y; Zhang B; Shan G; Li X
    Eur J Surg Oncol; 2016 Jan; 42(1):81-6. PubMed ID: 26615455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis.
    Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK
    World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer.
    Rajeev P; Ahmed S; Ezzat TM; Sadler GP; Mihai R
    Langenbecks Arch Surg; 2013 Mar; 398(3):377-82. PubMed ID: 23274361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.
    Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
    Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
    Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
    Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
    Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
    Ebina A; Sugitani I; Fujimoto Y; Yamada K
    Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.